Association between Diastolic Dysfunction with Inflammation and Oxidative Stress in Females ob/ob Mice
Carregando...
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2017
Editora
FRONTIERS MEDIA SA
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
CONTI, Filipe F.
DIAS, Danielle da Silva
MACHI, Jacqueline F.
PALOMINO, Zaira
CASARINI, Dulce E.
RODRIGUES, Bruno
ANGELIS, Kytia de
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
FRONTIERS IN PHYSIOLOGY, v.8, article ID 572, 10p, 2017
Resumo
Objective: To evaluate autonomic and cardiovascular function, as well as inflammatory and oxidative stress markers in ob/ob female mice. Methods: Metabolic parameters, cardiac function, arterial pressure (AP), autonomic, hormonal, inflammatory, and oxidative stressmarkers were evaluated in 12-weeks female wild-type (WT group) and ob/ob mice (OB group). Results: OB animals showed increased body weight, blood glucose, and triglyceride levels, along with glucose intolerance, when compared to WT animals. Ejection fraction (EF) and AP were similar between groups; however, the OB group presented diastolic dysfunction, as well as an impairment on myocardial performance index. Moreover, the OB group exhibited important autonomic dysfunction and baroreflex sensitivity impairment, when compared to WT group. OB group showed increased Angiotensin II levels in heart and renal tissues; decreased adiponectin and increased inflammatory markers in adipose tissue and spleen. Additionally, OB mice presented a higher damage to proteins and lipoperoxidation and lower activity of antioxidant enzymes in kidney and heart. Correlations were found between autonomic dysfunction with angiotensin II and inflammatory mediators, as well as between inflammation and oxidative stress. Conclusions: Our results showed that female adult ob/ob mice presented discrete diastolic dysfunction accompanied by autonomic disorder, which is associated with inflammation and oxidative stress in these animals.
Palavras-chave
obesity, cardiac dysfunction, autonomic, inflammation, female
Referências
- Abraham W. T., 2003, REV CARDIOVASC ME S2, V4, pS30
- AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
- Bella JN, 2002, CIRCULATION, V105, P1928, DOI 10.1161/01.CIR.0000015076.37047.D9
- Bowden MA, 2015, OBESITY, V23, P1166, DOI 10.1002/oby.21072
- Campagnaro BP, 2012, INT J HYPERTENS, DOI 10.1155/2012/968123
- Cardillo C, 2002, CIRCULATION, V106, P1783, DOI 10.1161/01.CIR.0000032260.01569.64
- COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772
- da Palma RK, 2016, J APPL PHYSIOL, V121, P1032, DOI 10.1152/japplphysiol.00130.2016
- Drel VR, 2006, DIABETES, V55, P3335, DOI 10.2337/db06-0885
- DZAU VJ, 1994, CIRCULATION, V89, P493
- Fernandez-Real JM, 2003, ENDOCR REV, V24, P278, DOI 10.1210/er.2002-0010
- Flues K, 2010, MATURITAS, V65, P267, DOI 10.1016/j.maturitas.2009.11.007
- FRIEDMAN JM, 1991, GENOMICS, V11, P1054, DOI 10.1016/0888-7543(91)90032-A
- Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80
- Hasty AH, 2001, J BIOL CHEM, V276, P37402, DOI 10.1074/jbc.M010176200
- Heeren MV, 2009, MATURITAS, V62, P200, DOI 10.1016/j.maturitas.2008.12.011
- Hilzendeger AM, 2010, J MOL MED-JMM, V88, P383, DOI 10.1007/s00109-009-0569-6
- HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495
- IRIGOYEN MC, 1995, HYPERTENSION, V26, P1111
- JAMES WPT, 1995, INT J OBESITY, V19, pS37
- Janszky I, 2004, J INTERN MED, V256, P421, DOI 10.1111/j.1365-2796.2004.01403.x
- JUHANVAGUE I, 1991, DIABETOLOGIA, V34, P457, DOI 10.1007/BF00403280
- Kajitani N, 2010, DIABETES RES CLIN PR, V88, P171, DOI 10.1016/j.diabres.2010.01.012
- KANNEL WB, 1976, ANN INTERN MED, V85, P447
- Kaseta JR, 1999, J CLIN ENDOCR METAB, V84, P1835, DOI 10.1210/jc.84.6.1835
- Kiencke S, 2010, EUR J HEART FAIL, V12, P951, DOI 10.1093/eurjhf/hfq110
- Kuo TBJ, 2010, ENDOCRINOLOGY, V151, P2613, DOI 10.1210/en.2009-1410
- Lau D. C., 2010, PRIM CARE DIABETES, V4, P24, DOI [10.1016/S1751-9918(10)60006-X, DOI 10.1016/S1751-9918(10)60006-X]
- Lombardi F, 1996, AM J CARDIOL, V77, P1283, DOI 10.1016/S0002-9149(96)00193-2
- Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523
- PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297
- Pinhas-Hamiel O, 2005, J PEDIATR-US, V146, P693, DOI 10.1016/j.jpeds.2004.12.042
- Policardo L, 2015, J DIABETES COMPLICAT, V29, P713, DOI 10.1016/j.jdiacomp.2014.12.008
- Pradhan AD, 2002, JAMA-J AM MED ASSOC, V288, P980, DOI 10.1001/jama.288.8.980
- Raimundo RD, 2013, TRANSL STROKE RES, V4, P488, DOI 10.1007/s12975-013-0263-4
- Regitz-Zagrosek V, 2010, CIRC J, V74, P1265, DOI 10.1253/circj.CJ-10-0196
- Reichelt ME, 2013, J MOL CELL CARDIOL, V65, P67, DOI 10.1016/j.yjmcc.2013.09.014
- Ridker PM, 2000, CIRCULATION, V101, P2149
- Ridker PM, 2000, CIRCULATION, V101, P1767
- Roncbi FA, 2007, J RENIN-ANGIO-ALDO S, V8, P34, DOI 10.3317/jraas.2007.005
- Russo C, 2011, J AM COLL CARDIOL, V57, P1368, DOI 10.1016/j.jacc.2010.10.042
- Saleh MC, 2000, BRAIN RES, V879, P105, DOI 10.1016/S0006-8993(00)02757-8
- Shimabukuro M, 2011, DIABETES CARE, V34, P686, DOI 10.2337/dc10-1141
- Silva SD, 2015, CIRC J, V79, P1372, DOI 10.1253/circj.CJ-14-1179
- Srinivasa S, 2015, J CLIN ENDOCR METAB, V100, P2873, DOI 10.1210/jc.2015-1461
- Tapsell LC, 2004, DIABETES CARE, V27, P2777, DOI 10.2337/diacare.27.12.2777
- Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487
- Verploegen SABW, 1997, FEBS LETT, V405, P237, DOI 10.1016/S0014-5793(97)00192-0
- Dantas APV, 2012, EXP DIABETES RES, DOI 10.1155/2012/570598
- Wichi R, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-14
- Xue BJ, 2007, AM J PHYSIOL-HEART C, V292, pH1770, DOI 10.1152/ajpheart.01011.2005
- ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0